Back to Archived Journals » Hypoxia » Volume 5
Original Research
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,462 | Dovepress* | 8,155+ | 798 | 8,953 | |
PubMed Central* | 307 | 104 | 411 | ||
Totals | 8,462 | 902 | 9,364 | ||
*Since 23 May 2017 |
View citations on PubMed Central and Google Scholar